SEC 13F Intelligence

Managers / Q4 2025 · view latest →

Sivik Global Healthcare LLC

CIK 0001596452 · 133 TACONIC RD, GREENWICH, CT, 06831 · 203-769-8600

Reported Value
$345M
Q4 2025
Positions
49
Filings on Record
30
2019–present window
Filed
Jan 21, 2026
original filing

Summary

Sivik Global Healthcare LLC reported $345M in U.S.-listed holdings across 49 positions for Q4 2025.

Its largest position, XBI, represents 8.0% of the portfolio.

Compared with Q3 2025, the fund opened 21 new positions and exited 16.

Portfolio Metrics

Turnover
+54.9%
vs prior filed quarter
Top-10 Concentration
+26.0%
share of reported value
Largest Position
+8.0%
State Street Spdr S P Biotech
New / Exited
21 / 16
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $186MQ4 ’18Q1 ’19: $271MQ2 ’19: $414MQ3 ’19: $198MQ4 ’19: $269MQ4 ’19Q1 ’20: $253MQ2 ’20: $302MQ3 ’20: $232MQ4 ’20: $245MQ4 ’20Q1 ’21: $274MQ2 ’21: $512MQ3 ’21: $419MQ4 ’21: $233MQ4 ’21Q1 ’22: $242MQ2 ’22: $176MQ3 ’22: $180MQ4 ’22: $213MQ4 ’22Q1 ’23: $233MQ2 ’23: $428MQ3 ’23: $198MQ4 ’23: $239MQ4 ’23Q1 ’24: $427MQ2 ’24: $278MQ3 ’24: $236MQ4 ’24: $190MQ4 ’24Q1 ’25: $185MQ2 ’25: $368MQ3 ’25: $344MQ4 ’25: $345MQ4 ’25Q1 ’26: $132Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 47.7%Other: 40.6%ETP: 8.0%ADR: 3.7%
  • Common Stock · 47.7% · $165M
  • Other · 40.6% · $140M
  • ETP · 8.0% · $27M
  • ADR · 3.7% · $13M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
PUT - SPY 100 @ 684 EXP 01/30/2026NEW+300300+$20M$20M
PUT - SPY 100 @ 682 EXP 01/30/2026NEW+250250+$17M$17M
PUT - SPY 100 @ 683 EXP 01/30/2026NEW+250250+$17M$17M
PUT - SPY 100 @ 681 EXP 01/30/2026NEW+250250+$17M$17M
PUT - SPY 100 @ 682 EXP 02/20/2026NEW+250250+$17M$17M
PUT - SPY 100 @ 688 EXP 01/30/2026NEW+250250+$17M$17M
PUT - SPY 100 @ 679 EXP 01/30/2026NEW+250250+$17M$17M
PUT - SPY 100 @ 680 EXP 02/20/2026NEW+250250+$17M$17M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2025

41 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1XBISTATE STREET SPDR S&P BIOTECHhistory →S&P BIOTECH7.96%$27M225.0K
2LLYELI LILLY & COhistory →COM2.18%$8M7.0K
3THCTENET HEALTHCAREhistory →COM NEW2.16%$7M37.5K
4MCKMCKESSON CORPhistory →COM2.14%$7M9.0K
5HCAHCA HEALTHCARE INChistory →COM2.03%$7M15.0K
6TMOTHERMO FISHER SCIENTIFIC INC.history →COM2.02%$7M12.0K
7CAHCARDINAL HEALTHhistory →COM1.94%$7M32.5K
8BSXBOSTON SCIENTIFIC CORPORATIONhistory →COM1.94%$7M70.0K
9VRTXVERTEX PHARMACEUTICALS INC.history →COM1.81%$6M13.8K
10UHSUNIV HEALTH SVChistory →CLASS B1.77%$6M28.0K
11CORCENCORA INChistory →COM1.76%$6M18.0K
12ISRGINTUITIVE SURGhistory →COM NEW1.64%$6M10.0K
13EHCENCOMPASS HEALTH CORPhistory →COM1.54%$5M50.0K
14DHRDANAHER CORPhistory →COM1.53%$5M23.0K
15ABTABBOTT LABShistory →COM1.45%$5M40.0K
16AAGILENT TECHNOLOGIES INChistory →COM1.38%$5M35.0K
17ABBVABBVIE INChistory →COM1.33%$5M20.0K
18SYKSTRYKER CORPhistory →COM1.33%$5M13.0K
19MDTMEDTRONIC INChistory →SHS1.25%$4M45.0K
20MTDMETTLER TOLEDOhistory →COM1.21%$4M3.0K
21SNNSMITH & NEPHEWhistory →SPDN ADR NEW1.19%$4M125.0K
22RGENREPLIGEN CORPhistory →COM1.19%$4M25.0K
23UNHUNITEDHEALTH GRPhistory →COM1.15%$4M12.0K
24BDXBECTON DICKINSON COhistory →COM1.13%$4M20.0K
25HUMHUMANA INC.history →COM1.11%$4M15.0K
26NVONOVO-NORDISK A/Shistory →ADR1.11%$4M75.0K
27AZNNASTRAZENECA PLC-SPONS ADRhistory →SPONSORED ADR1.07%$4M40.0K
28BIOBIO-RAD LABS Ahistory →CL A1.06%$4M12.0K
29BIIBBIOGEN INChistory →COM1.02%$4M20.0K
30GMEDGLOBUS MEDICALhistory →CL A1.01%$3M40.0K
31MRKMERCK & COCOM0.92%$3M30.0K
32SGRYSURGERY PARTNERS INCCOM0.90%$3M200.0K
33GILDGILEAD SCIENCES INCCOM0.89%$3M25.0K
34BRKRBRUKER CORPORATIONCOM0.89%$3M65.0K
35EWEDWARDS LIFESCIENCESCOM0.87%$3M35.0K
36GEHCGE HEALTHCARE TECHNOLOGYCOMMON STOCK0.83%$3M35.0K
37S24SELECT MEDICAL HOLDINGS CORPCOM0.82%$3M190.0K
38TECHBIO-TECHNE CORPCOM0.77%$3M45.0K
39CGONCG ONCOLOGY INCCOM0.42%$1M35.0K
40ARGXARGEN SE - ADRSPONSORED ADR0.37%$1M1.5K
41ALNYALNYLAM PHARMACEUTICALSCOM0.35%$1M3.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$132M34Apr 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$345M49Jan 21, 202613F-HRchanges · EDGAR ↗
Q3 2025$344M44Oct 23, 202513F-HRchanges · EDGAR ↗
Q2 2025$368M46Jul 25, 202513F-HRchanges · EDGAR ↗
Q1 2025$185M31Apr 22, 202513F-HRchanges · EDGAR ↗
Q4 2024$190M38Jan 23, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M35Nov 6, 202413F-HRchanges · EDGAR ↗
Q2 2024$278M38Jul 29, 202413F-HRchanges · EDGAR ↗
Q1 2024$427M47May 1, 202413F-HRchanges · EDGAR ↗
Q4 2023$239M39Feb 5, 202413F-HRchanges · EDGAR ↗
Q3 2023$198M33Nov 7, 202313F-HRchanges · EDGAR ↗
Q2 2023$428M43Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023$233M40May 8, 202313F-HRchanges · EDGAR ↗
Q4 2022$213M39Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$180M41Nov 4, 202213F-HRchanges · EDGAR ↗
Q2 2022$176M38Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$242M49May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$233M45Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$419M43Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$512M49Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$274M47May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$245M38Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$232M38Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$302M52Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$253M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$269M50Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$198M45Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$414M62Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$271M61May 8, 201913F-HRchanges · EDGAR ↗
Q4 2018$186M48Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.